New Delhi, Feb 27 : India’s pharmaceutical industry has witnessed a sharp drop of 11 per cent in regulatory violation instances in 2024, according to a report. The regulatory violation instances which entail Official Action Indicated (OAI) tag by the US drug regulator, stood at 23 per cent in 2014. The drop suggests that the…
…
A platform for change and progress. At Blitz India Business, our vision is to be a transformative platform that elevates the role of business and industry in driving India’s journey towards Viksit Bharat 2047. We are dedicated to fostering innovation, championing sustainability, and promoting inclusivity, while building a bridge for collaboration and progress.
Quick Links
Get important news delivered directly to your inbox and stay connected!